CM Management’s Heron Therapeutics HRTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.24M	Hold	600,000	–	–	1.13%	31
2025 Q1	$1.32M	Sell	600,000 -100,000	-14%	-$220K	1.33%	32
2024 Q4	$1.07M	Buy	700,000 +200,000	+40%	+$306K	0.96%	40
2024 Q3	$995K	Buy	500,000 +200,000	+67%	+$398K	0.79%	45
2024 Q2	$1.05M	Hold	300,000	–	–	0.96%	39
2024 Q1	$831K	Sell	300,000 -25,000	-8%	-$69.3K	0.7%	47
2023 Q4	$553K	Sell	325,000 -125,000	-28%	-$213K	0.44%	53
2023 Q3	$464K	Sell	450,000 -50,000	-10%	-$51.5K	0.49%	49
2023 Q2	$580K	Buy	500,000 +150,000	+43%	+$174K	0.57%	50
2023 Q1	$529K	Buy	350,000 +100,000	+40%	+$151K	0.63%	44
2022 Q4	$625K	Sell	250,000 -25,000	-9%	-$62.5K	0.75%	46
2022 Q3	$1.16M	Buy	275,000 +75,000	+38%	+$317K	1.3%	28
2022 Q2	$558K	Hold	200,000	–	–	0.59%	52
2022 Q1	$1.14M	Buy	200,000 +150,000	+300%	+$858K	0.96%	35
2021 Q4	$457K	Sell	50,000 -10,000	-17%	-$91.4K	0.35%	76
2021 Q3	$641K	Buy	60,000 +10,000	+20%	+$107K	0.48%	66
2021 Q2	$776K	Hold	50,000	–	–	0.56%	63
2021 Q1	$811K	Buy	50,000 +35,000	+233%	+$568K	0.6%	65
2020 Q4	$317K	Buy	+15,000	New	+$317K	0.29%	70